News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bayer AG (BAYZF)'s CEO To Quit In 2016, CFO Moves Over To Lead Strategy


6/4/2014 6:57:43 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

German drugmaker Bayer AG said on Tuesday its chief executive Marijn Dekkers is to step down at the end of 2016 for family reasons and the group's chief financial officer is moving over later this year to take charge of strategy to ensure continuity. "In line with his own wishes, the contract of Dr. Marijn Dekkers will be extended by just two years on expiration of the initial five-year period. Dekkers cited family reasons for extending his contract only until the end of 2016," the company said in a statement. Meanwhile finance chief Werner Baumann, aged 51, is to take on the newly created role of chief strategy and portfolio officer in October, to "ensure continuity in key aspects of Bayer's future development".

Help employers find you! Check out all the jobs and post your resume.


comments powered by Disqus
Bayer AG
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES